# Discovery Potential Hub Genes and Pathways in Keloid Fibroblast Development Based on Bioinformatics Analysis

**Authors:** Boao Zhao, Wei Zhang, Wende Yao, Xinyi Li, Tao Yang, Hui Cheng, Xiaojing Li

PMC · DOI: 10.1155/ijog/2089205 · International Journal of Genomics · 2025-11-21

## TL;DR

This study identifies key genes and potential treatments for keloid development using bioinformatics analysis of fibroblast data.

## Contribution

The study discovers three hub genes (BMP4, POSTN, WNT5A) and potential therapeutic candidates for keloid fibroblast hyperplasia.

## Key findings

- Six key genes were identified, with BMP4, POSTN, and WNT5A showing significant association with keloids.
- Paricalcitol and phosphine were identified as potential therapeutic candidates for keloid treatment.
- A diagnosis model was established to predict therapeutic targets in keloid fibroblast development.

## Abstract

Keloid is a common pathological scar tissue, which invades the surrounding normal skin and leads to symptoms such as pain, pruritus, erythema, and edema, thereby impacting the quality of life. In this study, we conducted bioinformatics analysis of keloid fibroblasts and normal skin tissue to identify DEGs and the pathways involved in the mechanism of keloid fibroblast proliferation.

GSE145725 was downloaded from the Gene Expression Omnibus (GEO) database, including nine keloid fibroblasts and 10 normal tissue fibroblast samples. GSE158395 included four lesional and three nonlesional samples from keloid patients, and six normal skin tissue samples were also evaluated. Through bioinformatics analysis, we established diagnosis model, and at the same time, we predicted therapeutic targets in the DSigDB database.

Six key genes were screened out by bioinformatics analysis, including BMP4, SPP1, HIF1α, POSTN, WNT5A, and SMAD3. Subsequently, three of these genes (BMP4, POSTN, and WNT5A) were found to be significantly associated with keloids. Paricalcitol and phosphine were identified as potential therapeutic candidates.

This study identified three hub genes—BMP4, POSTN, and WNT5A—that are closely linked to keloid fibroblast hyperplasia and may serve as potential biomarkers for inhibiting keloid fibroblast hyperplasia. Further molecular and animal studies are needed to fully understand the mechanisms of keloid development.

## Linked entities

- **Genes:** BMP4 (bone morphogenetic protein 4) [NCBI Gene 652], SPP1 (secreted phosphoprotein 1) [NCBI Gene 6696], HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091], POSTN (periostin) [NCBI Gene 10631], WNT5A (Wnt family member 5A) [NCBI Gene 7474], SMAD3 (SMAD family member 3) [NCBI Gene 4088]
- **Chemicals:** paricalcitol (PubChem CID 5281104), phosphine (PubChem CID 24404)
- **Diseases:** keloid (MONDO:0005348)

## Full-text entities

- **Genes:** WNT5A (Wnt family member 5A) [NCBI Gene 7474] {aka hWNT5A}, SMAD3 (SMAD family member 3) [NCBI Gene 4088] {aka HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, BMP4 (bone morphogenetic protein 4) [NCBI Gene 652] {aka BMP2B, BMP2B1, MCOPS6, OFC11, ZYME}, SPP1 (secreted phosphoprotein 1) [NCBI Gene 6696] {aka BNSP, BSPI, ETA-1, OPN}, POSTN (periostin) [NCBI Gene 10631] {aka OSF-2, OSF2, PDLPOSTN, PN}
- **Diseases:** Keloid (MESH:D007627), erythema (MESH:D004890), edema (MESH:D004487), pruritus (MESH:D011537), pain (MESH:D010146)
- **Chemicals:** Paricalcitol (MESH:C084656), phosphine (MESH:C044646)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12635863/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12635863/full.md

## References

64 references — full list in the complete paper: https://tomesphere.com/paper/PMC12635863/full.md

---
Source: https://tomesphere.com/paper/PMC12635863